ZA802987B - Thiadiazolo- and oxadiazolotetrahy droisoquinoline compounds - Google Patents

Thiadiazolo- and oxadiazolotetrahy droisoquinoline compounds

Info

Publication number
ZA802987B
ZA802987B ZA00802987A ZA802987A ZA802987B ZA 802987 B ZA802987 B ZA 802987B ZA 00802987 A ZA00802987 A ZA 00802987A ZA 802987 A ZA802987 A ZA 802987A ZA 802987 B ZA802987 B ZA 802987B
Authority
ZA
South Africa
Prior art keywords
oxadiazolotetrahy
droisoquinoline
thiadiazolo
compounds
oxadiazolotetrahy droisoquinoline
Prior art date
Application number
ZA00802987A
Other languages
English (en)
Inventor
G Girard
W Bondinell
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of ZA802987B publication Critical patent/ZA802987B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA00802987A 1979-07-02 1980-05-20 Thiadiazolo- and oxadiazolotetrahy droisoquinoline compounds ZA802987B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02

Publications (1)

Publication Number Publication Date
ZA802987B true ZA802987B (en) 1981-05-27

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00802987A ZA802987B (en) 1979-07-02 1980-05-20 Thiadiazolo- and oxadiazolotetrahy droisoquinoline compounds

Country Status (30)

Country Link
EP (1) EP0023761B1 (xx)
JP (1) JPS5610192A (xx)
KR (1) KR840000396B1 (xx)
AR (1) AR225925A1 (xx)
AT (1) ATE6515T1 (xx)
AU (1) AU531641B2 (xx)
BG (1) BG51250A3 (xx)
CA (1) CA1129415A (xx)
CS (1) CS215064B2 (xx)
DD (1) DD151750A5 (xx)
DE (1) DE3066826D1 (xx)
DK (1) DK151029C (xx)
ES (1) ES492971A0 (xx)
FI (1) FI67221C (xx)
GR (1) GR69206B (xx)
HU (1) HU179382B (xx)
IE (1) IE50290B1 (xx)
IL (1) IL60426A (xx)
IN (1) IN160542B (xx)
MX (1) MX6317E (xx)
NO (1) NO801951L (xx)
NZ (1) NZ194156A (xx)
PH (1) PH17042A (xx)
PL (2) PL230619A1 (xx)
PT (1) PT71458A (xx)
RO (1) RO79707A (xx)
SU (1) SU1072809A3 (xx)
YU (1) YU171180A (xx)
ZA (1) ZA802987B (xx)
ZW (1) ZW14680A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
DK151029C (da) 1988-03-07
IE50290B1 (en) 1986-03-19
GR69206B (xx) 1982-05-07
KR830002791A (ko) 1983-05-30
KR840000396B1 (ko) 1984-03-30
NZ194156A (en) 1983-03-15
CA1129415A (en) 1982-08-10
YU171180A (en) 1983-09-30
AU531641B2 (en) 1983-09-01
BG51250A3 (en) 1993-03-15
IE801352L (en) 1981-01-02
ES8105736A1 (es) 1981-06-01
DK274280A (da) 1981-01-03
PL225377A1 (xx) 1981-08-21
PL230619A1 (xx) 1981-12-11
FI802112A (fi) 1981-01-03
DE3066826D1 (en) 1984-04-12
IL60426A0 (en) 1980-09-16
IL60426A (en) 1984-03-30
EP0023761B1 (en) 1984-03-07
SU1072809A3 (ru) 1984-02-07
PL127098B1 (en) 1983-09-30
PT71458A (en) 1980-07-01
HU179382B (en) 1982-10-28
FI67221B (fi) 1984-10-31
RO79707A (ro) 1982-08-17
AU5967780A (en) 1981-01-15
ES492971A0 (es) 1981-06-01
IN160542B (xx) 1987-07-18
ZW14680A1 (en) 1980-09-24
AR225925A1 (es) 1982-05-14
DK151029B (da) 1987-10-12
MX6317E (es) 1985-04-01
CS215064B2 (en) 1982-07-30
EP0023761A1 (en) 1981-02-11
JPS5610192A (en) 1981-02-02
ATE6515T1 (de) 1984-03-15
PH17042A (en) 1984-05-17
FI67221C (fi) 1985-02-11
DD151750A5 (de) 1981-11-04
NO801951L (no) 1981-01-05

Similar Documents

Publication Publication Date Title
GB2052478B (en) Guanidinothiazole compounds
JPS5594363A (en) Phenoxyphenylpiperidine compound
JPS5610183A (en) 199hydroxyypgi compound
JPS5686134A (en) Eicosapentanoate compound
IL59287A0 (en) 14-methoxymorphinan-6-one compounds
JPS55124743A (en) 99aminoalkylfluorene compound
JPS56113779A (en) Compound
GB2125037B (en) 2-acetoxymethyl-penam compounds
ZA806146B (en) Heterocyclici compounds
JPS55136288A (en) Betaalactam contained compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
JPS5667369A (en) Phthaloperinone compound
ZA802765B (en) Novel compounds
JPS55113769A (en) 44substitutedd22iminoimidazolidine compound
GB2047708B (en) Butyloctyl-magnesium compounds
IL61133A0 (en) 6-methylene-morphinan compounds
JPS55136264A (en) Pyridineacetoamide compound
ZA807948B (en) 2-oxybenzimidazoline compounds
JPS56100858A (en) Halootriazinyl compound
JPS5632575A (en) Antiifreeze compound
GB2111983B (en) Cyclopent-4-en-5-olone compounds
DE3064156D1 (en) 1-halo-4-decene compounds
JPS55162734A (en) 11aamethanootxa compounds
JPS55130958A (en) Benzenesulfinamide compound
JPS55111487A (en) Furochromone compound